Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 7.44 USD 0.27%
Market Cap: 957.5m USD

Intrinsic Value

The intrinsic value of one NEO stock under the Base Case scenario is 13.88 USD. Compared to the current market price of 7.44 USD, Neogenomics Inc is Undervalued by 46%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NEO Intrinsic Value
13.88 USD
Undervaluation 46%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Neogenomics Inc

Valuation History Unavailable

Historical valuation for NEO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Neogenomics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neogenomics Inc

Current Assets 573.9m
Cash & Short-Term Investments 358.1m
Receivables 151.2m
Other Current Assets 64.6m
Non-Current Assets 1B
PP&E 167.4m
Intangibles 854.1m
Other Non-Current Assets 6m
Efficiency

Free Cash Flow Analysis
Neogenomics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Neogenomics Inc

Revenue
672.4m USD
Cost of Revenue
-374.5m USD
Gross Profit
297.9m USD
Operating Expenses
-383m USD
Operating Income
-85.1m USD
Other Expenses
7.5m USD
Net Income
-77.6m USD
Fundamental Scores

NEO Profitability Score
Profitability Due Diligence

Neogenomics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
ROIC is Increasing
31/100
Profitability
Score

Neogenomics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

NEO Solvency Score
Solvency Due Diligence

Neogenomics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Negative Net Debt
43/100
Solvency
Score

Neogenomics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NEO Price Targets Summary
Neogenomics Inc

Wall Street analysts forecast NEO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEO is 11.09 USD with a low forecast of 8.08 USD and a high forecast of 15.75 USD.

Lowest
Price Target
8.08 USD
9% Upside
Average
Price Target
11.09 USD
49% Upside
Highest
Price Target
15.75 USD
112% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Neogenomics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NEO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

NEO Insider Trading
Buy and sell transactions by insiders

NEO News

Other Videos
What is the Intrinsic Value of one NEO stock?

The intrinsic value of one NEO stock under the Base Case scenario is 13.88 USD.

Is NEO stock undervalued or overvalued?

Compared to the current market price of 7.44 USD, Neogenomics Inc is Undervalued by 46%.

Back to Top